Stay updated with breaking news from Care Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Early identification and treatment of Alzheimer's disease need the use of trustworthy and cost-effective screening technology. Researchers at Sweden's Karolinska Institutet discovered that the quantity of tau, a protein that plays an important role in the development of severe dementia, is linked to a kind of sugar molecule in the blood.
Scientists believe the discovery could pave the way for a much less invasive and less expensive screening process
Early detection and treatment of Alzheimer's disease require the use of dependable and cost-effective screening technologies. Researchers at Sweden's Karolinska Institutet have revealed that the level of tau, a protein that plays a vital role in the development of severe dementia, is associated with a kind of sugar molecule in the blood.
Early diagnosis and treatment of Alzheimer's disease requires reliable and cost-effective screening methods.
Researchers say there may be a connection between a sugar molecule in the blood and the build-up of tau proteins in the brain. The discovery could help lead to earlier diagnoses of Alzheimer's disease.